DOE PAGES title logo U.S. Department of Energy
Office of Scientific and Technical Information

Title: Real‐time quantification and supplementation of bioreactor amino acids to prolong culture time and maintain antibody product quality

Abstract

Abstract Real‐time monitoring of cell cultures in bioreactors can enable expedited responses necessary to correct potential batch failure perturbations which may normally go undiscovered until the completion of the batch and result in failure. Currently, analytical technologies are dedicated to real‐time monitoring of bioreactor parameters such as pH, dissolved oxygen, and temperature, nutrients such as glucose and glutamine, or metabolites such as lactate. Despite the importance of amino acids as the building blocks of therapeutic protein products, other than glutamine their concentrations are not commonly measured. Here, we present a study into amino acid monitoring, supplementation strategies, and how these techniques may impact the cell growth profiles and product quality. We used preliminary bioreactor runs to establish baselines by determining initial amino acid consumption patterns, the results of which were used to select a pool of amino acids which gets depleted in the bioreactor. These amino acids were combined into blends which were supplemented into bioreactors during a subsequent run, the concentrations of which were monitored using a mass spectrometry based at‐line method we developed to quickly assess amino acid concentrations from crude bioreactor media. We found that these blends could prolong culture life, reversing a viable cell density decreasemore » that was leading to batch death. Additionally, we assessed how these strategies might impact protein product quality, such as the glycan profile. The amino acid consumption data were aligned with the final glycan profiles in principal component analysis to identify which amino acids are most closely associated with glycan outcomes.« less

Authors:
 [1];  [2];  [1];  [1]; ORCiD logo [1];  [1];  [3]; ORCiD logo [4]; ORCiD logo [1]
  1. U.S. Food and Drug Administration, Center for Drug Evaluation and Research, Office of Product Quality, Office of Biotechnology Products, Division of Biotechnology Review and Research II Silver Spring Maryland
  2. U.S. Food and Drug Administration, Center for Drug Evaluation and Research, Office of Testing and Research, Division of Product Quality Research Silver Spring Maryland
  3. U.S. Food and Drug Administration, Center for Drug Evaluation and Research, Office of Product Quality, Office of Biotechnology Products, Division of Biotechnology Review and Research II Silver Spring Maryland, Sartorius Stedim North America Inc Corporate Research Bohemia NY
  4. Department of Chemical Engineering University of Massachusetts Lowell Massachusetts
Publication Date:
Sponsoring Org.:
USDOE
OSTI Identifier:
1564340
Alternate Identifier(s):
OSTI ID: 1564341
Resource Type:
Published Article
Journal Name:
Biotechnology Progress
Additional Journal Information:
Journal Name: Biotechnology Progress Journal Volume: 35 Journal Issue: 6; Journal ID: ISSN 8756-7938
Publisher:
Wiley Blackwell (John Wiley & Sons)
Country of Publication:
United States
Language:
English

Citation Formats

Powers, David N., Wang, Yifan, Fratz‐Berilla, Erica J., Velugula‐Yellela, Sai Rashmika, Chavez, Brittany, Angart, Phillip, Trunfio, Nicholas, Yoon, Seongkyu, and Agarabi, Cyrus. Real‐time quantification and supplementation of bioreactor amino acids to prolong culture time and maintain antibody product quality. United States: N. p., 2019. Web. doi:10.1002/btpr.2894.
Powers, David N., Wang, Yifan, Fratz‐Berilla, Erica J., Velugula‐Yellela, Sai Rashmika, Chavez, Brittany, Angart, Phillip, Trunfio, Nicholas, Yoon, Seongkyu, & Agarabi, Cyrus. Real‐time quantification and supplementation of bioreactor amino acids to prolong culture time and maintain antibody product quality. United States. https://doi.org/10.1002/btpr.2894
Powers, David N., Wang, Yifan, Fratz‐Berilla, Erica J., Velugula‐Yellela, Sai Rashmika, Chavez, Brittany, Angart, Phillip, Trunfio, Nicholas, Yoon, Seongkyu, and Agarabi, Cyrus. Wed . "Real‐time quantification and supplementation of bioreactor amino acids to prolong culture time and maintain antibody product quality". United States. https://doi.org/10.1002/btpr.2894.
@article{osti_1564340,
title = {Real‐time quantification and supplementation of bioreactor amino acids to prolong culture time and maintain antibody product quality},
author = {Powers, David N. and Wang, Yifan and Fratz‐Berilla, Erica J. and Velugula‐Yellela, Sai Rashmika and Chavez, Brittany and Angart, Phillip and Trunfio, Nicholas and Yoon, Seongkyu and Agarabi, Cyrus},
abstractNote = {Abstract Real‐time monitoring of cell cultures in bioreactors can enable expedited responses necessary to correct potential batch failure perturbations which may normally go undiscovered until the completion of the batch and result in failure. Currently, analytical technologies are dedicated to real‐time monitoring of bioreactor parameters such as pH, dissolved oxygen, and temperature, nutrients such as glucose and glutamine, or metabolites such as lactate. Despite the importance of amino acids as the building blocks of therapeutic protein products, other than glutamine their concentrations are not commonly measured. Here, we present a study into amino acid monitoring, supplementation strategies, and how these techniques may impact the cell growth profiles and product quality. We used preliminary bioreactor runs to establish baselines by determining initial amino acid consumption patterns, the results of which were used to select a pool of amino acids which gets depleted in the bioreactor. These amino acids were combined into blends which were supplemented into bioreactors during a subsequent run, the concentrations of which were monitored using a mass spectrometry based at‐line method we developed to quickly assess amino acid concentrations from crude bioreactor media. We found that these blends could prolong culture life, reversing a viable cell density decrease that was leading to batch death. Additionally, we assessed how these strategies might impact protein product quality, such as the glycan profile. The amino acid consumption data were aligned with the final glycan profiles in principal component analysis to identify which amino acids are most closely associated with glycan outcomes.},
doi = {10.1002/btpr.2894},
journal = {Biotechnology Progress},
number = 6,
volume = 35,
place = {United States},
year = {Wed Aug 28 00:00:00 EDT 2019},
month = {Wed Aug 28 00:00:00 EDT 2019}
}

Journal Article:
Free Publicly Available Full Text
Publisher's Version of Record
https://doi.org/10.1002/btpr.2894

Citation Metrics:
Cited by: 6 works
Citation information provided by
Web of Science

Save / Share:

Works referenced in this record:

Controllability Analysis of Protein Glycosylation in Cho Cells
journal, February 2014


Bioreactor Process Parameter Screening Utilizing a Plackett-Burman Design for a Model Monoclonal Antibody
journal, June 2015

  • Agarabi, Cyrus D.; Schiel, John E.; Lute, Scott C.
  • Journal of Pharmaceutical Sciences, Vol. 104, Issue 6
  • DOI: 10.1002/jps.24420

The art of CHO cell engineering: A comprehensive retrospect and future perspectives
journal, December 2015


Fermentanomics informed amino acid supplementation of an antibody producing mammalian cell culture
journal, April 2013

  • Read, Erik K.; Bradley, Scott A.; Smitka, Tim A.
  • Biotechnology Progress, Vol. 29, Issue 3
  • DOI: 10.1002/btpr.1728

Glycosylation profiles of therapeutic antibody pharmaceuticals
journal, November 2011

  • Wacker, Christoph; Berger, Christoph N.; Girard, Philippe
  • European Journal of Pharmaceutics and Biopharmaceutics, Vol. 79, Issue 3
  • DOI: 10.1016/j.ejpb.2011.06.010

Effects of amino acid additions on ammonium stressed CHO cells
journal, May 2005


Antibody therapeutics:: isotype and glycoform selection
journal, August 2007


Designed Amino Acid Feed in Improvement of Production and Quality Targets of a Therapeutic Monoclonal Antibody
journal, October 2015


Glycoprofiling effects of media additives on IgG produced by CHO cells in fed-batch bioreactors: Glycoprofiling Effects of Media Additives on IgG
journal, August 2015

  • Kildegaard, Helene Faustrup; Fan, Yuzhou; Sen, Jette W.
  • Biotechnology and Bioengineering, Vol. 113, Issue 2
  • DOI: 10.1002/bit.25715

Impact of media and antifoam selection on monoclonal antibody production and quality using a high throughput micro-bioreactor system
journal, November 2017

  • Velugula-Yellela, Sai Rashmika; Williams, Abasha; Trunfio, Nicholas
  • Biotechnology Progress, Vol. 34, Issue 1
  • DOI: 10.1002/btpr.2575

Industry and regulatory experience of the glycosylation of monoclonal antibodies
journal, July 2011

  • Read, Erik K.; Park, Jun T.; Brorson, Kurt A.
  • Biotechnology and Applied Biochemistry, Vol. 58, Issue 4
  • DOI: 10.1002/bab.35

Fermentanomics: Relating quality attributes of a monoclonal antibody to cell culture process variables and raw materials using multivariate data analysis
journal, August 2015

  • Rathore, Anurag S.; Kumar Singh, Sumit; Pathak, Mili
  • Biotechnology Progress, Vol. 31, Issue 6
  • DOI: 10.1002/btpr.2155

Purification and Analytics of a Monoclonal Antibody from Chinese Hamster Ovary Cells Using an Automated Microbioreactor System
journal, January 2019

  • Velugula-Yellela, Sai Rashmika; Powers, David N.; Angart, Phillip
  • Journal of Visualized Experiments, Issue 147
  • DOI: 10.3791/58947

CHO cell line specific prediction and control of recombinant monoclonal antibody N -glycosylation : Cell Line Specific Prediction of MAb
journal, June 2013

  • Grainger, Rhian K.; James, David C.
  • Biotechnology and Bioengineering, Vol. 110, Issue 11
  • DOI: 10.1002/bit.24959

Post-translational structural modifications of immunoglobulin G and their effect on biological activity
journal, September 2014

  • Hmiel, Laura K.; Brorson, Kurt A.; Boyne, Michael T.
  • Analytical and Bioanalytical Chemistry, Vol. 407, Issue 1
  • DOI: 10.1007/s00216-014-8108-x

Unique carbohydrate-carbohydrate interactions are required for high affinity binding between Fc RIII and antibodies lacking core fucose
journal, July 2011

  • Ferrara, C.; Grau, S.; Jager, C.
  • Proceedings of the National Academy of Sciences, Vol. 108, Issue 31
  • DOI: 10.1073/pnas.1108455108

The use of ‘Omics technology to rationally improve industrial mammalian cell line performance: The Use of ‘Omics Technology
journal, October 2015

  • Lewis, Amanda M.; Abu-Absi, Nicholas R.; Borys, Michael C.
  • Biotechnology and Bioengineering, Vol. 113, Issue 1
  • DOI: 10.1002/bit.25673

Score normalization in multimodal biometric systems
journal, December 2005


Amino acid and manganese supplementation modulates the glycosylation state of erythropoietin in a CHO culture system
journal, January 2006

  • Crowell, Christopher K.; Grampp, Gustavo E.; Rogers, Gary N.
  • Biotechnology and Bioengineering, Vol. 96, Issue 3
  • DOI: 10.1002/bit.21141

Therapeutic monoclonal antibody N-glycosylation – Structure, function and therapeutic potential
journal, March 2018


Control of misincorporation of serine for asparagine during antibody production using CHO cells
journal, April 2010

  • Khetan, Anurag; Huang, Yao-ming; Dolnikova, Jana
  • Biotechnology and Bioengineering, Vol. 107, Issue 1
  • DOI: 10.1002/bit.22771